StockTipsArenaBeta

BUY Emcure Pharmaceuticals Limited — Kush Bohra

BUYEmcure Pharmaceuticals Limited
Emcure Pharmaceuticals share price target & all analyst calls

byKush BohraHorizon: NA (inferred Swing (≤2wk))18 Sept 2026via NDTV Profit

Entry₹2,070Inferred
Target₹2,200
Total upside +6.28% (call closed)
Stop loss₹1,900-8.21% risk
At expiry₹1,946.51 Oct 2026, 3:30 pm
Expired-5.97%
Follow Kush Bohra for new calls(34% target hit, 220 closed calls)Get alertsWatch EMCURE for new buy/sell callsGet alertsSee 204 active Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 1 Oct 2026
5 supporting2 neutral0 opposing
Supports the BUY call (5)

Emcure Pharmaceuticals Limited (NSE: EMCURE) Reveals Strong Revenue Growth in FY26 Presentation

NewsGoogle News·28 Sept · 2d ago

(opens in new tab)

Emcure Pharmaceuticals reports over $1 billion operating revenue in FY26 with 16.6% growth

NewsGoogle News·25 Sept · 5d ago

(opens in new tab)

Emcure Pharma: Here's Why ICICI Direct Calls It A High-Conviction 'Buy'

NewsNdtv-Profit·7 Sept · 3w ago

(opens in new tab)

Broker’s call: Emcure Pharma (Buy)

NewsHbl·4 Sept · 4w ago

(opens in new tab)

1 advisor has an active short-term BUY call on this stock

Advisor consensus · adjacent horizon·8 Jul · 3mo ago

Neutral / worth noting (2)

Market Trading Guide: Acme Solar, Bharat Dynamics among 5 stock recommendations for Wednesday

NewsEt-Markets·15 Sept · 2w ago

(opens in new tab)

Market Trading Guide: Emcure Pharma among 2 stock recommendations for Monday

NewsEt-Markets·6 Sept · 3w ago

(opens in new tab)
Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Emcure Pharmaceuticals

All analyst calls on Emcure Pharmaceuticals

More from Kush Bohra

Every call and its outcome